Metastatic Colorectal Cancer, symptoms, Metastatic Colorectal Cancer, treatment

XELODA (capecitabine) in Metastatic Colorectal Cancer
XELODA is an oral chemotherapy medication approved by the FDA for treating metastatic colorectal cancer when fluoropyrimidine (FLOO-or-o-purr-IM-ah-deen) therapy alone is preferred Complete ...
- oral-cancer-drugs.net/considering_xeloda/colon_cancer.asp
metastatic colorectal cancer
... tumor-shrinking agent for patients with metastatic breast cancer or metastatic colorectal cancer. metastatic colorectal cancer Information resource on an orally administered chemotherapeutic tumor ...
- www.oral-cancer-medication.net/metastatic-colorectal-cancer.htm
Metastatic Colorectal Cancer: Systemic Treatment in the New ...
... Growth Factor Inhibitors COX-2 Inhibitors Biological Markers References Figures Tables Metastatic Colorectal Cancer: Systemic Treatment in the New Millennium Anelisa K. Coutinho, MD, Caio Max S. Rocha Lima ...
- professional.cancerconsultants.com/ccj_colon.aspx?id=23332
|| DukeMedNews || Experimental Cancer Drug Shrinks Tumors and Extends ...
... drug to prove that it can shrink tumors and extend survival in patients with metastatic colorectal cancer, according to a national clinical trial led by... entire site News Experts Images Media Kits Audio ...
- dukemednews.org/news/article.php?id=6612
National Cancer Institute - Bevacizumab Improves Survival in ...
... Society of Clinical Oncology (ASCO). Bevacizumab (Avastin™) Improves Survival in Metastatic Colorectal Cancer Keywords Colorectal cancer; Avastin; bevacizumab; anti-angiogenesis; VEGF Summary Patients ...
- www.cancer.gov/clinicaltrials/results/bevacizumab-and-colorectal-cancer0601
Metastatic Colorectal Cancer Treatment, from Avastin.com
... fluorouracil [5-FU]-based chemotherapy) for treatment of people diagnosed with metastatic colorectal cancer for the first time. expand collapse Home About Avastin What Is Avastin? How Is ...
- www.avastin.com/avastin/home.m
A Phase I Trial of 90Y-Anti-Carcinoembryonic Antigen Chimeric T84.66 ...
... Antigen Chimeric T84.66 Radioimmunotherapy with 5-Fluorouracil in Patients with Metastatic Colorectal Cancer Jeffrey Y. C. Wong 1 , Stephen Shibata 2 , Lawrence E. Williams 3 , Cheuk S. Kwok 1 , An Liu 1 ...
- clincancerres.aacrjournals.org/cgi/content/full/9/16/5842
XELODA (capecitabine) – Clinical Data in Metastatic Colorectal ...
... Provides clinical data information to healthcare professionals on the treatment of metastatic colorectal cancer with Xeloda Complete Product Information | Safety ...
- www.xeloda.com/hcp/clinical_colorectal.asp
- 6/18/2005
FDA Approves First Angiogenesis Inhibitor to Treat Colorectal Cancer
... approved Avastin (bevacizumab) as a first-line treatment for patients with metastatic colorectal cancer -- cancer that has spread to other parts of the body. Avastin, a monoclonal antibody, is ...
- www.fda.gov/bbs/topics/NEWS/2004/NEW01027.html
Aetna - End of Life Project - Colorectal cancer : Colorectal ...
Go back to... Colorectal cancer Colorectal cancer Colorectal cancer is the abnormal growth of cancer cells in the muscular tube that makes up the lower digestive tract (large intestine). Colon ...
- www.healthwise.net/aetna_eol/Content/StdDocument.aspx?DOCHWID=uh1565&f=aetna_eol

metastatic colorectal cancer

XELODA (capecitabine) in Metastatic Colorectal Cancer

metastatic colorectal cancer

Metastatic Colorectal Cancer: Systemic Treatment in the New ...

|| DukeMedNews || Experimental Cancer Drug Shrinks Tumors and Extends ...

National Cancer Institute - Bevacizumab Improves Survival in ...

Metastatic Colorectal Cancer Treatment, from Avastin.com

A Phase I Trial of 90Y-Anti-Carcinoembryonic Antigen Chimeric T84.66 ...

XELODA (capecitabine) – Clinical Data in Metastatic Colorectal ...

FDA Approves First Angiogenesis Inhibitor to Treat Colorectal Cancer

Aetna - End of Life Project - Colorectal cancer : Colorectal ...